New study suggests GLP-1 drugs like Ozempic and Wegovy may raise fracture risk by 11% in adults 65 and older with type 2 ...

New research suggests GLP-1 drugs may increase the risk of bone and tendon injuries and other conditions, including ...

Fact checked by Nick Blackmer New research suggests prolonged GLP-1 use may be linked to a higher risk of osteoporosis and ...

My mother also had osteoporosis.

Gina Woods, MD, shares three case scenarios of sequential treatment decision-making for long-term therapy and discusses research that can inform clinical decisions.

On Monday, the Food and Drug Administration issued a new draft guidance that requires drug manufacturers to conduct long-term nonclinical bone quality studies for osteoporosis treatments. The agency ...

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

The Food and Drug Administration on Tuesday approved an osteoporosis drug that represents the first new treatment approach in nearly two decades — a strategy based on a rare gene mutation in people ...

Continued denosumab treatment is associated with a lower risk for diabetes in adults with osteoporosis older than 65 years, found a large-scale cohort study in Taiwan. Denosumab, used in osteoporosis ...

New research suggests popular GLP-1 weight loss drugs like Ozempic, Wegovy, and Mounjaro may raise the risk of osteoporosis and gout. A large five-year study found slightly higher rates of bone ...